PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-104.07%
G&A reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.85%
Operating expenses reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
-86.85%
Total costs reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
-35.35%
Interest expense reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
86.85%
EBITDA change of 86.85% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
86.85%
Income change of 86.85% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
-35.35%
Other expenses reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
87.46%
Income change of 87.46% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
87.46%
Income change of 87.46% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
87.70%
EPS change of 87.70% while CRON.TO is flat. Bruce Berkowitz would examine quality.
87.70%
Diluted EPS change of 87.70% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.